Tuesday, 09 August 2022
This website uses cookies. By using our site you agree to our privacy policy

Username:
Password:
Lost username/password
Create an account
  • Home
  • About Us
    • Accreditation
    • Contact Us
  • Reference
    • Newsletters
    • FAQ Library
    • COVID-19 Resource Center
    • What are MPNs?
  • Continuing Education
  • Resources
    • Articles
    • Tools
  • What Are Mpns Banner
  • How can the mutational profile in myeloproliferative neoplasms (MPN) help to inform diagnosis and prognosis?
  • Risk-adapted Therapy for PV
  • What Are Mpns Banner
  • How can the mutational profile in myeloproliferative neoplasms (MPN) help to inform diagnosis and prognosis?
  • Risk-adapted Therapy for PV

What's New

Continuing Education
Risk-adapted Therapy for PV
Jerry L. Spivak, MD, MACP
What are MPNs?
What are Myeloproliferative neoplasms (MPNs)?
FAQ
How is red blood cell (RBC) transfusion used to manage anemia in myelofibrosis (MF) patients?
Srdan Verstovsek, MD, PhD
FAQ
How can the mutational profile in myeloproliferative neoplasms (MPN) help to inform diagnosis and prognosis?
Aaron T. Gerds, MD, MS
FAQ
How is risk assessed in PV and how does this risk inform treatment decisions?
Jerry L. Spivak, MD, MACP
FAQ
What are the treatment options for MF-related anemia?
Raajit K. Rampal, MD, PhD
View all FAQs

How is risk assessed in PV and how does this risk inform treatment decisions?
How is risk assessed in PV and how does this risk inform treatment decisions?
Jerry L. Spivak, MD, MACP

Novel Agents and Treatment Strategies for Relapsed/Refractory MF

How is red blood cell (RBC) transfusion used to manage anemia in myelofibrosis (MF) patients?
Using RBC transfusion
for Anemia in MF patients

Srdan Verstovsek, MD, PhD

Untitled Document
MedicalEd Digest
Subscribe Today to join our MedicalEd Digest
mailing list!
Your email address will not be shared with any third party, nor sold.

Risk-adapted Therapy for PV
How can the mutational profile in myeloproliferative neoplasms (MPN) help to inform diagnosis and prognosis?
What are Myeloproliferative Neoplasms (MPNs)?

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMDS.com | ManagingLymphoma.com | PracticalOncologist.com | MediComWorldwide.com

© 2022 MediCom Worldwide, Inc. All rights reserved

  • Privacy, Terms, and Conditions
  • Contact Us